Overview
Xilong Deng practices in Guangzhou, China. Deng is rated as an Advanced expert by MediFind in the treatment of COVID-19. Their top areas of expertise are COVID-19, Severe Acute Respiratory Syndrome (SARS), Pneumonia, and H1N1 Influenza.
Their clinical research consists of co-authoring 45 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 25 articles and participated in 1 clinical trial in the study of COVID-19.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- COVID-19Deng isAdvanced. Learn about COVID-19.
- Severe Acute Respiratory Syndrome (SARS)
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- Avian InfluenzaDeng isExperienced. Learn about Avian Influenza.
- FluDeng isExperienced. Learn about Flu.
- H1N1 InfluenzaDeng isExperienced. Learn about H1N1 Influenza.
- PneumoniaDeng isExperienced. Learn about Pneumonia.